Showing 1791-1800 of 5643 results for "".
- Luminopia Announces FDA Approval of Digital Therapeutic to Improve Vision in Children with Lazy Eyehttps://modernod.com/news/luminopia-announces-fda-approval-of-digital-therapeutic-to-improve-vision-in-children-with-lazy-eye/2480369/Luminopia announced that the FDA has granted de novo premarket approval for Luminopia One as a prescription therapy to improve vision in children with amblyopia (lazy eye), the leading cause of vision loss in children. Luminopia One is indicated for improvement in visual acuity in child
- Aurinia Completes Patient Enrollment In Phase 2/3 Trial of Voclosporin for the Treatment of Dry Eyehttps://modernod.com/news/aurinia-completes-patient-enrollment-in-phase-2-3-trial-of-voclosporin-for-the-treatment-of-dry-eye/2477914/Aurinia Pharmaceuticals announced it has completed enrollment for the phase 2/3 AUDREY clinical trial evaluating voclosporin ophthalmic solution (VOS) for the potential treatment of dry eye syndrome (DES). “Voclosporin’s proven mechanism of action as a novel calcineurin inhibitor gives us
- Nicox Announces Data Collection Complete, NCX 470 Phase 3b Whistler Glaucoma Trialhttps://modernod.com/news/nicox-announces-data-collection-complete-ncx-470-phase-3b-whistler-glaucoma-trial/2482709/Nicox announced today that the last patient completed their final visit in the Whistler phase 3b clinical trial investigating the efficacy of NCX470 to lower IOP. This marks the end of their
- Medicare Sticks With E/M Pay Plan Over Some Groups’ Objectionshttps://modernod.com/news/medicare-sticks-with-e-m-pay-plan-over-some-groups-objections/2478136/The Trump administration is sticking with a plan to boost certain Medicare pay for many primary care and other specialties focused heavily on office visits while lowering that for other groups to balance these increased costs, according to a Medscape
- Analysis: Ophthalmology Lost More Patient Volume Due to COVID-19 Than Any Other Specialtyhttps://modernod.com/news/analysis-55-percent-fewer-americans-sought-hospital-care-in-march-april-due-to-covid-19/2477738/A new large analysis revealed that ophthalmology lost more patient volume due to the COVID-19 pandemic than any other medical specialty. The analysis of over 2 million patient visits and encounters
- New 10 Year Warranty for Haag-Streit Slit Lampshttps://modernod.com/news/new-10-year-warranty-for-haag-streit-slit-lamps/2479858/As of October 2018, Haag-Streit Diagnostics is introducing a 10 year limited warranty for its slit lamps. For more information on Haag-Streit’s slit lamps and the new warranty program, visit
- Heidelberg Engineering Showcases Technologies to Enhance the Future of Imaging Technology at ARVOhttps://modernod.com/news/heidelberg-engineering-showcases-technologies-to-enhance-the-future-of-imaging-technology-at-arvo/2482771/Heidelberg Engineering announced a portfolio of innovations aimed at redefining image quality, clinical research, and patient care in ophthalmology at ARVO. According to Heidelberg, Chameleon Imaging Research Platform is des
- Glaukos Expands its Preserflo MicroShunt Relationship With Santen Via New License Agreementhttps://modernod.com/news/glaukos-expands-its-preserflo-microshunt-relationship-with-santen-via-new-license-agreement/2479228/Glaukos announced that it has entered into a new development and commercialization license agreement with Santen Pharmaceutical for the Preserflo MicroShunt (development code: DE-128), superseding the previous collaboration and distribution agreements between the two parties. Financial ter
- Discovery of a New Drug for Diabetic Retinopathyhttps://modernod.com/news/discovery-of-a-new-drug-for-diabetic-retinopathy/2478858/A potentially effective treatment for diabetic retinopathy has been developed by an Université de Montréal (UdeM) scientist and investigator at Maisonneuve-Rosemont Hospital Research Centre (MRH-RC). Working with research scientist Pam Tsuruda of the
- Santen to Present Glaucoma/OcularHypertension Data at AAO 2020 Virtualhttps://modernod.com/news/santen-to-present-glaucoma-ocularhypertension-data-at-aao-2020-virtual/2478519/Santen announced that the following talks on glaucoma and ocular hypertension will be presented at the American Academy of Ophthalmology (AAO) Virtual 2020 meeting. Poster Topic: MicroShunt (or DE-128), an investigational surgical glaucoma implant designed to reduce intrao